- On 25 September, Hifas da Terra received the Nutraforum 2024 Award for Best Nutraceutical Company in Spain during the 10th edition of the Farmaforum Congress, highlighting its leadership in the food supplement industry.
- Hifas da Terra is focused on disruptive innovation from a One Health perspective, seeking to meet the needs of the population with safe solutions supported by its own scientific evidence.
- Since 2021, Hifas da Terra has experienced exponential growth in international sales, exceeding 500%, solidifying its international expansion.
Hifas da Terra has been awarded the Nutraforum 2024 Award for Best Nutraceutical Company, recognising its commitment to innovation and the development of high-quality nutraceutical products. Nutraforum is part of a Spanish pharmaceutical industry event: Farmaforum.
The award was presented to Claudia Fernández, Hifas da Terra’s Innovation Hub Manager, by Lois Fraiz Ares, Director of Nutraforum, during the tenth-anniversary celebration of the Farmaforum congress. The ceremony attracted over 7,200 industry professionals, with participation from key figures including Eugenio Pérez de Lema Carmona, General Director of Farmaforum; Eduardo Sanz Sánchez, Director of the Farmaforum Congress; and Marcos Muiños Docampo, Commercial Director of Farmaforum.
growth of more than 500%
Hifas da Terra continues to solidify its leadership in the research and commercialisation of functional mushroom-based nutraceuticals, achieving over 500% growth in international sales outside the European Union since 2021.
Fernández emphasised the importance of evaluating profitability and feasibility from the project’s inception, particularly when navigating regulations and potential costs associated with Novel Foods.
Safe solutions supported by scientific evidence
“The most critical phases of the projects are undoubtedly the initial ones, in which we focus on analysing the profitability and feasibility of the project. If Novel Food’s processing is involved, it would be necessary to contemplate the investment required for this process and the deadlines so that the project is economically viable and can reach the market within the established timeframe,”
International growth
The increase in sales abroad partly explains the growth and expansion of Hifas da Terra. 10% of its total sales now come from countries outside the EU. Fernández explained that growth in these markets has been exponential and highlighted the importance of adapting to local regulations, tariff barriers and the challenges arising from geopolitical tensions.
This award not only reaffirms Hifas da Terra’s position in the nutraceutical sector but also underscores its commitment to innovation and sustainable development in advancing health through science and biotechnology.
Hifas da Terra
Hifas da Terra is a biotech based on research and innovation, with a high degree of specialisation in the development of nutraceuticals from functional mushrooms, with processes and products protected by patent or kept under industrial secrecy.
Health professionals from different countries trust in the formulas of Hifas da Terra, forming a multidisciplinary prescription network of more than 20,000 experts with whom it collaborates through its subsidiaries and distributors in Europe, the United States, the Middle East and new emerging countries.
Hifas da Terra has a team led by Dr. Catalina Fernández de Ana Portela, in addition to groups of national and international scientific advisors. The company develops formulas harnessing the bioactive properties of functional mushrooms, from research to production and purification